Cornerstone Planning Group LLC Supernus Pharmaceuticals, Inc. Transaction History
Cornerstone Planning Group LLC
- $407 Billion
- Q4 2024
A detailed history of Cornerstone Planning Group LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 15 shares of SUPN stock, worth $585. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15Holding current value
$585% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SUPN
# of Institutions
284Shares Held
60.5MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$405 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$239 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$199 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$112 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$103 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.09B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...